• Latest Posts

Nuance Pharma receives clearance to begin clinical trials with Ensifentrine in China

Beyond Biotech podcast 10: Endpoint Health, Nevrargenics, Triastek

Five emerging biotech hubs in the Asia-Pacific region

First patient on Innovative Cellular Therapeutics’ study looking at treating colorectal cancer

Lung cancer trial patients responding well to combination treatment offered by HUTCHMED and AstraZeneca

HUTCHMED drug in colorectal cancer trial meets primary endpoint


Epigenic Therapeutics raises $20M for gene editing technology

Sanofi and Innovent Biologics to collaborate on oncology medicines and boost China presence

In Depth 4 Aug 2022

The biggest Asia-Pacific biotech investments in July 2022

Patients with advanced cancer set to benefit from ProfoundBio’s new drug

Ascletis announces FDA clearance of oral drug to conduct study in mild to moderate COVID-19 patients

Zenas BioPharma gets Chinese approval for thyroid eye disease treatment study